Quality-of-life implications of risk-reducing cancer surgery.

about

Quality-of-life implications of risk-reducing cancer surgery.

Item

http://www.wikidata.org/entity/Q48229444

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Quality-of-life implications of risk-reducing cancer surgery.

@en

Quality-of-life implications of risk-reducing cancer surgery.

@nl

type

Item

label

Quality-of-life implications of risk-reducing cancer surgery.

@en

Quality-of-life implications of risk-reducing cancer surgery.

@nl

prefLabel

Quality-of-life implications of risk-reducing cancer surgery.

@en

Quality-of-life implications of risk-reducing cancer surgery.

@nl

P1476

Quality-of-life implications of risk-reducing cancer surgery

@en

P2093

T M Tuttle

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers

Premature menopause or early menopause: long-term health consequences

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.

Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy.

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.

The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.

P304

e121-e130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BJS.10725

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

J Hui

Ariella M Altman

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29341149

http://www.w3.org/2001/XMLSchema#string